Dr. Fischer brand sheds generic packaging in US

Company has begun marketing some of its eye-care products under its own name.

February 19, 2013 22:45
3 minute read.
Dr. Fischer products

fischer370. (photo credit: NIV ELIS)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


American pharmacy shoppers have been buying Dr. Fischer’s products for years – they just didn’t know it. Major chains including Rite Aid, CVS and Duane Read have sold the Israeli entrepreneur’s products under their own generic brands, with only an innocuous line of white lettering reading “Made in Israel” ever hinting that the product was made by Dr. Eli Fischer.

“We made Purell wipes for Purell before Pfizer bought them,” says Fischer, who founded the company with his wife, Dvora, in 1965.

Having built up its US product sales to millions of dollars annually over the course of 10 years, Fischer Pharmaceuticals decided it was time to emerge from behind the generic packaging.

“If you have a brand, it’s harder to undercut,” Fischer says, “so we decided to develop our brand in the United States.”

Though it will continue selling a wide range of products, such as sunscreen and vitamins, through US retailers using generic branding, the company has begun marketing some of its eyecare products under its own name.

Key among them is an eyelid wipe that, due to its sterile hydrating formula, does not require washing, one of Fischer’s proudest recent innovations.

“We, by chance, understand both eyes and wipes,” he says, adding that keeping eyelids clean from debris, pollen, allergens and bacteria can be an important preventive measure against eye complications and deterioration of eyesight. “Eye hygiene is as important as dental hygiene.”

Fischer should know. He was a member of the research team that developed the glaucoma drug EPPY, once the leading treatment for the disease, and worked as a research assistant to Nobel Prize winner Dr. George Wald, who discovered the important linkage between vitamin A and vision.

Fischer, 77, was born in Czechoslovakia and immigrated to Israel with his family when he was three, on the same day the German army entered Prague.

He studied biochemistry and microbiology at the Hebrew University of Jerusalem and earned a doctorate in pharmacology at the University of California Medical Center and a fellowship at Harvard.

Fischer got his feet wet in the corporate world in the Untied States. But his heart was in Israel. After a stint at Barnes-Hind, where Dvora learned quality control, he took some seed money to start his own business in Bnei Brak. His experience in the US paid off.

He was the first Israeli manufacturer, for example, who had learned how to sterilize plastic bottles for eye drops.

In 1973, as he was awaiting the lengthy process of Health Ministry approval for his betodine formula, the Yom Kippur War broke out. With the approval of regulators, they began distributing the product to help treat soldiers’ burns.

Today, the company is co-chaired by two of Fischer’s three daughters, Nurit and Sigal, while he remains active in its operations as an “abbassador” for the brand, especially its expansion in the US.

The company employs 700 people and has facilities in Bnei Brak, the Galilee and Tzrifin. It has expanded to five main production areas: children’s products, sunscreen, cosmetic treatment, toiletries and nutritional supplements.

The bronze-colored bottle of their Ultrasol sunscreen, a staple at beachside kiosks as well as pharmacies, exemplifies their pharmaceutical philosophy.

“Everything is anti-aging, even shampoo,” Fischer says. While any old bathroom soap could clean your hair for the short term, he says, repeated use would start to take its toll on your hair and scalp. The products they create, whether sunscreen, shampoo or vitamins, are designed not to aggravate cells’ natural deterioration but prevent it.

“Aging happens in the whole body, not just the face,” Fischer says. “But you can slow down the process.”

In addition to exporting two daily shipping containers each to Europe and the US, the company also has a healthy presence in the West Bank, where its products are marked in English, Hebrew and Arabic.

“Peace, we must say, is also good for business,” says Fischer, a proud peace activist. “If there’s peace, we’ll sell 10 times as much.”

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings